JP2018530606A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018530606A5 JP2018530606A5 JP2018536071A JP2018536071A JP2018530606A5 JP 2018530606 A5 JP2018530606 A5 JP 2018530606A5 JP 2018536071 A JP2018536071 A JP 2018536071A JP 2018536071 A JP2018536071 A JP 2018536071A JP 2018530606 A5 JP2018530606 A5 JP 2018530606A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- polysaccharide
- activity
- biological function
- micelle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011782 vitamin Substances 0.000 claims 40
- 229940088594 vitamin Drugs 0.000 claims 40
- 229930003231 vitamin Natural products 0.000 claims 38
- 235000013343 vitamin Nutrition 0.000 claims 38
- 150000003722 vitamin derivatives Chemical class 0.000 claims 29
- 239000008187 granular material Substances 0.000 claims 28
- 150000004676 glycans Chemical class 0.000 claims 18
- 229920001282 polysaccharide Polymers 0.000 claims 18
- 239000005017 polysaccharide Substances 0.000 claims 18
- 230000008827 biological function Effects 0.000 claims 17
- 230000000694 effects Effects 0.000 claims 16
- 239000000693 micelle Substances 0.000 claims 16
- 239000013543 active substance Substances 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- -1 cyclic anhydride Chemical class 0.000 claims 3
- 230000004614 tumor growth Effects 0.000 claims 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 2
- 125000003636 chemical group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000000524 functional group Chemical group 0.000 claims 2
- 230000002209 hydrophobic effect Effects 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 229940123237 Taxane Drugs 0.000 claims 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 229960002685 biotin Drugs 0.000 claims 1
- 235000020958 biotin Nutrition 0.000 claims 1
- 239000011616 biotin Substances 0.000 claims 1
- 229940127093 camptothecin Drugs 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 230000010261 cell growth Effects 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 229940127089 cytotoxic agent Drugs 0.000 claims 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002224 folic acids Chemical class 0.000 claims 1
- 230000006870 function Effects 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- NCYVXEGFNDZQCU-UHFFFAOYSA-N nikethamide Chemical compound CCN(CC)C(=O)C1=CC=CN=C1 NCYVXEGFNDZQCU-UHFFFAOYSA-N 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000011236 particulate material Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562233112P | 2015-09-25 | 2015-09-25 | |
| US62/233,112 | 2015-09-25 | ||
| PCT/US2016/053626 WO2017053920A1 (en) | 2015-09-25 | 2016-09-25 | Drug formulation based on particulates comprising polysaccharide-vitamin conjugate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018530606A JP2018530606A (ja) | 2018-10-18 |
| JP2018530606A5 true JP2018530606A5 (https=) | 2019-12-12 |
| JP6877049B2 JP6877049B2 (ja) | 2021-05-26 |
Family
ID=58387558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536071A Active JP6877049B2 (ja) | 2015-09-25 | 2016-09-25 | 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US10517961B2 (https=) |
| EP (1) | EP3352796B1 (https=) |
| JP (1) | JP6877049B2 (https=) |
| KR (1) | KR20180058759A (https=) |
| CN (1) | CN108135917B (https=) |
| AU (1) | AU2016326747A1 (https=) |
| CA (1) | CA2995029C (https=) |
| IL (1) | IL257652A (https=) |
| WO (1) | WO2017053920A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3026454C (en) | 2015-06-04 | 2023-07-04 | Crititech, Inc. | Collection device and methods for use |
| EP3854381A1 (en) | 2016-04-04 | 2021-07-28 | Crititech, Inc. | Methods for solid tumor treatment |
| CA3063420A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| WO2018231908A1 (en) | 2017-06-14 | 2018-12-20 | Crititech, Inc. | Methods for treating lung disorders |
| KR20250057947A (ko) | 2017-10-03 | 2025-04-29 | 크리티테크, 인크. | 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달 |
| EP3883394A2 (en) * | 2018-11-20 | 2021-09-29 | Sphera Encapsulation S.r.l. | Multi-layered particles |
| CN111956806B (zh) * | 2020-09-03 | 2023-04-07 | 四川大学 | 一种药物载体、胶束、药剂及其制备方法和应用 |
| KR102619293B1 (ko) * | 2021-01-14 | 2023-12-29 | 주식회사 엔바이오스 | Sp-fa 접합체를 유효성분으로 함유하는 항암용 조성물 |
| CN113082219B (zh) * | 2021-04-07 | 2023-02-17 | 中国科学院大学温州研究院(温州生物材料与工程研究所) | 一种基于π-π作用的疏水药物的增溶方法 |
| CN118477122B (zh) * | 2024-07-16 | 2024-09-24 | 中科创导(山东)生物科技有限公司 | 一种混合酶发酵生产治疗眼疾的中药制剂及其制备方法 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166800A (en) | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
| JPS6019790A (ja) | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
| FR2601675B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2601676B1 (fr) | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Procede de preparation du taxol et du desacetyl-10 taxol |
| US5004758A (en) | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
| US4942184A (en) | 1988-03-07 | 1990-07-17 | The United States Of America As Represented By The Department Of Health And Human Services | Water soluble, antineoplastic derivatives of taxol |
| US5059699A (en) | 1990-08-28 | 1991-10-22 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
| US5278324A (en) | 1990-08-28 | 1994-01-11 | Virginia Tech Intellectual Properties, Inc. | Water soluble derivatives of taxol |
| HK1002252A1 (en) | 1991-04-02 | 1998-08-07 | Biotech Australia Pty. Limited | Oral delivery systems for microparticles |
| TW197439B (https=) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| CA2071160A1 (en) | 1991-07-31 | 1993-02-01 | Vittorio Farina | Asymmetric synthesis of taxol side chain |
| US5350866A (en) | 1991-09-23 | 1994-09-27 | Bristol-Myers Squibb Company | 10-desacetoxytaxol derivatives |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
| US5272171A (en) | 1992-02-13 | 1993-12-21 | Bristol-Myers Squibb Company | Phosphonooxy and carbonate derivatives of taxol |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| US5440056A (en) | 1992-04-17 | 1995-08-08 | Abbott Laboratories | 9-deoxotaxane compounds |
| JPH08500973A (ja) | 1992-05-21 | 1996-02-06 | ザ ペン ステイト リサーチ ファウンデーション | タキソール、関連タキサン及び他の新規な抗癌／抗ウイルス性化合物原料としてのイチイ培養組織 |
| AU4406793A (en) | 1992-06-04 | 1993-12-30 | Clover Consolidated, Limited | Water-soluble polymeric carriers for drug delivery |
| US5248796A (en) | 1992-06-18 | 1993-09-28 | Bristol-Myers Squibb Company | Taxol derivatives |
| GB9213077D0 (en) | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
| US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
| US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5254580A (en) | 1993-01-19 | 1993-10-19 | Bristol-Myers Squibb Company | 7,8-cyclopropataxanes |
| US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| WO1994005282A1 (en) | 1992-09-04 | 1994-03-17 | The Scripps Research Institute | Water soluble taxol derivatives |
| CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
| FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
| FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| US5411984A (en) | 1992-10-16 | 1995-05-02 | Virginia Tech Intellectual Properties, Inc. | Water soluble analogs and prodrugs of taxol |
| US5380751A (en) | 1992-12-04 | 1995-01-10 | Bristol-Myers Squibb Company | 6,7-modified paclitaxels |
| US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| WO1994020089A1 (en) | 1993-03-09 | 1994-09-15 | Enzon, Inc. | Taxol-based compositions with enhanced bioactivity |
| US5412092A (en) | 1993-04-23 | 1995-05-02 | Bristol-Myers Squibb Company | N-substituted 2-azetidinones |
| US5449720A (en) | 1993-05-24 | 1995-09-12 | Biotech Australia Pty Limited | Amplification of the VB12 uptake system using polymers |
| US5395850A (en) | 1994-03-10 | 1995-03-07 | Bristol-Myers Squibb Company | 6,7-epoxy paclitaxels |
| JP3499246B2 (ja) | 1995-11-02 | 2004-02-23 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | カンプトテシン誘導体の製造法 |
| GB9600438D0 (en) | 1996-01-10 | 1996-03-13 | Pharmacia Spa | Hexacyclic camptothecin analogues, and process for preparing them |
| GB9601779D0 (en) | 1996-01-30 | 1996-04-03 | Pharmacia Spa | 9, 10 Disubstituted camptothecin derivatives |
| GB9702807D0 (en) | 1997-02-12 | 1997-04-02 | Pharmacia & Upjohn Spa | Alkynyl-substituted camptothecins and process for their preparation |
| US5977348A (en) | 1997-07-25 | 1999-11-02 | National Starch And Chemical Investment Holding Corporation | Polysaccharide modification in densified fluid |
| GB9715821D0 (en) | 1997-07-25 | 1997-10-01 | Pharmacia & Upjohn Spa | Amidino-camptothecin derivatives |
| GB9721069D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
| GB9721070D0 (en) | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Bioactive derivatives of camptothecin |
| EP1044977B1 (en) | 1999-03-09 | 2002-05-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. | Camptothecin derivatives having antitumor activity |
| AU4564200A (en) | 1999-04-29 | 2000-11-17 | Aventis Pharma S.A. | Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
| AU5521400A (en) | 1999-05-18 | 2000-12-05 | Powerpulse Holding Ag | Radiation guidance system |
| WO2001064194A2 (en) | 2000-02-29 | 2001-09-07 | Janssen Pharmaceutica N.V. | Farnesyl protein transferase inhibitor combinations with camptothecin compounds |
| GB0008928D0 (en) | 2000-04-11 | 2000-05-31 | Pharmacia & Upjohn Spa | A method of administering an antitumour compound |
| JP2003535063A (ja) | 2000-06-01 | 2003-11-25 | ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティー | 放射線医薬としてのナノ粒子のバイオコンジュゲート |
| WO2002067995A1 (en) * | 2001-02-26 | 2002-09-06 | Council Of Scientific And Industrial Research | Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
| US20030157161A1 (en) | 2001-05-01 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents |
| TW200306314A (en) | 2002-04-16 | 2003-11-16 | Tanabe Seiyaku Co | Liquid preparation comprising camptothecin derivative and pharmaceutical composition producible by lyophilizing the preparation |
| US6593334B1 (en) | 2002-05-02 | 2003-07-15 | The University Of North Carolina At Chapel Hill | Camptothecin-taxoid conjugates as antimitotic and antitumor agents |
| ITRM20020306A1 (it) | 2002-05-31 | 2003-12-01 | Sigma Tau Ind Farmaceuti | Esteri in posizione 20 di camptotecine. |
| WO2003101998A1 (en) | 2002-06-03 | 2003-12-11 | California Pacific Medical Center | Nitrogen-based homo-camptothecin derivatives |
| AU2003243397A1 (en) | 2002-06-03 | 2003-12-19 | California Pacific Medical Center | Homo-camptothecin derivatives |
| US6759416B2 (en) | 2002-08-06 | 2004-07-06 | Panorama Research, Inc. | Anticancer conjugates of camptothecin and unsaturated fatty acids |
| WO2010002982A1 (en) * | 2008-07-01 | 2010-01-07 | Cognosci, Inc. | Methods of treating cancer with apoe peptides |
| JP2010126533A (ja) | 2008-11-28 | 2010-06-10 | Bio Verde:Kk | 高機能化抗癌剤 |
| CA2756072A1 (en) * | 2009-03-30 | 2010-10-14 | Cerulean Pharma Inc. | Polymer-agent conjugates, particles, compositions, and related methods of use |
| WO2011130716A2 (en) | 2010-04-16 | 2011-10-20 | Access Pharmaceuticals, Inc. | A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
| WO2012030745A1 (en) * | 2010-08-30 | 2012-03-08 | Access Pharmaecuticals, Inc | MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS |
| CN103501821A (zh) * | 2011-03-08 | 2014-01-08 | 艾克塞斯制药公司 | 用于递送活性剂穿过生物膜的靶向纳米载体系统 |
| WO2013033230A1 (en) | 2011-08-29 | 2013-03-07 | Isis Pharmaceuticals, Inc. | Oligomer-conjugate complexes and their use |
| US8968790B2 (en) | 2011-12-09 | 2015-03-03 | Shaker A. Mousa | Nanoformulation of vitamin D derivatives and/or vitamin D metabolites |
| CN103936880A (zh) * | 2012-12-14 | 2014-07-23 | 苏州友林生物科技有限公司 | 纳米级颗粒型辅料 |
| CN103992417A (zh) | 2012-12-14 | 2014-08-20 | 苏州友林生物科技有限公司 | 用于包裹药物化合物的辅料的制备方法及该辅料 |
| CN103120794B (zh) * | 2012-12-14 | 2014-04-30 | 苏州友林生物科技有限公司 | 协同起效的药用辅料及其抗肿瘤应用 |
| CN104434792B (zh) * | 2013-09-12 | 2018-03-23 | 中国科学院深圳先进技术研究院 | 聚合物胶束及其制备方法和抗肿瘤药物组合物、制剂及其制备方法 |
| WO2015126841A1 (en) | 2014-02-18 | 2015-08-27 | Plasmatech Biopharmaceuticals, Inc. | Nutritional and therapeutic mucoadhesive formulations |
-
2016
- 2016-09-25 AU AU2016326747A patent/AU2016326747A1/en not_active Abandoned
- 2016-09-25 CA CA2995029A patent/CA2995029C/en active Active
- 2016-09-25 JP JP2018536071A patent/JP6877049B2/ja active Active
- 2016-09-25 KR KR1020187011217A patent/KR20180058759A/ko not_active Withdrawn
- 2016-09-25 WO PCT/US2016/053626 patent/WO2017053920A1/en not_active Ceased
- 2016-09-25 US US15/745,066 patent/US10517961B2/en active Active
- 2016-09-25 CN CN201680055476.2A patent/CN108135917B/zh active Active
- 2016-09-25 EP EP16849831.9A patent/EP3352796B1/en active Active
-
2018
- 2018-02-21 IL IL257652A patent/IL257652A/en unknown
-
2019
- 2019-11-08 US US16/678,908 patent/US10994024B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018530606A5 (https=) | ||
| Wang et al. | Self‐assembling prodrugs by precise programming of molecular structures that contribute distinct stability, pharmacokinetics, and antitumor efficacy | |
| CN103030140A (zh) | 透明质酸修饰的氧化石墨烯及其药物组合物的制备方法与应用 | |
| JP6877049B2 (ja) | 多糖類−ビタミン共役体を含む粒状物に基づく薬物製剤 | |
| Chen et al. | EGF-functionalized single-walled carbon nanotubes for targeting delivery of etoposide | |
| Sugahara et al. | Complete regression of xenografted human carcinomas by a paclitaxel–carboxymethyl dextran conjugate (AZ10992) | |
| RU2008112144A (ru) | Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества | |
| JP2011507838A5 (https=) | ||
| SI2231189T1 (en) | A delivery system for administering pharmaceutical active substances that are poorly soluble in water | |
| CN105012271B (zh) | 一种共担载阿霉素和trail的白蛋白纳米粒靶向制剂及制备方法 | |
| CN105267979B (zh) | 聚合法制备棉酚及其衍生物聚多巴胺纳米载体的方法 | |
| Ebrahimnejad et al. | Characterization, blood profile and biodistribution properties of surface modified PLGA nanoparticles of SN-38 | |
| Pal et al. | Advances in engineering of low molecular weight hydrogels for chemotherapeutic applications | |
| CN105879052B (zh) | 一种果胶-多臂聚乙二醇自组装制备纳米药物的方法 | |
| CN110665009B (zh) | 一种促肿瘤血管正常化纳米化吉西他滨及其应用 | |
| CN103301073B (zh) | 一种甲氨喋呤靶向纳米粒缓释制剂及其制备方法 | |
| CN108524951A (zh) | 一种具有肝肿瘤靶向作用的索拉菲尼纳米制剂 | |
| Lv et al. | Influence of unsaturated fatty acids on the antitumor activity of polymeric conjugates grafted with cabazitaxel against prostate cancer | |
| JP2011507840A5 (https=) | ||
| CN105616384A (zh) | 一种包载紫杉醇的tpgs-还原性白蛋白纳米粒制剂及制备方法 | |
| ITMI20071321A1 (it) | Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali | |
| Miao et al. | Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo | |
| CN116515011A (zh) | 一种基于透明质酸的两亲性接枝共聚物及其制备方法和应用 | |
| CN109666087B (zh) | 一种环糊精类衍生物及其制备方法与应用 | |
| CN102078302B (zh) | 一种小檗胺壳聚糖-琼胶纳米粒的制备方法 |